Project Details
Description
ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria (AHP)
Status | Active |
---|---|
Effective start/end date | 2/15/21 → 2/28/26 |
Funding
- Alnylam Pharmaceuticals, Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.